Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Survival analysis techniques in angina pectoris trials.

D R Bristol1, J V Castellana

  • 1Development Department, CIBA-GEIGY Corporation, Summit, New Jersey 07901.

Statistics in Medicine
|March 1, 1990
PubMed
Summary

New methods using survival analysis can effectively evaluate angina pectoris treatments, even when exercise stress tests are stopped early due to fatigue. This approach improves clinical trial efficacy assessment.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinical equivalence.

Journal of biopharmaceutical statistics·1999
Same author

p-value adjustments for subgroup analyses.

Journal of biopharmaceutical statistics·1997
Same author

Alcohol-containing mouthwashes and oropharyngeal cancer: a spurious association due to underascertainment of confounders?

American journal of epidemiology·1996
Same author

Determining equivalence and the impact of sample size in anti-infective studies: a point to consider.

Journal of biopharmaceutical statistics·1996
Same author

Planning survival studies to compare a treatment to an active control.

Journal of biopharmaceutical statistics·1993
Same author

Sample size determination using an interim analysis.

Journal of biopharmaceutical statistics·1993

Area of Science:

  • Cardiology
  • Clinical Trials
  • Biostatistics

Background:

  • Exercise stress tests measure walking time to moderate angina to assess angina pectoris treatments.
  • Test results are often censored due to fatigue or other reasons for premature termination.
  • This censoring complicates the accurate evaluation of treatment efficacy.

Purpose of the Study:

  • To propose and evaluate the use of survival analysis techniques for clinical trials where walking time to angina is censored.
  • To compare the performance of survival analysis with other methods in analyzing such data.

Main Methods:

  • Utilized survival analysis techniques, specifically addressing censored data.
  • Applied methods to data from a placebo-controlled, multicentre clinical trial for angina pectoris.
  • Conducted simulations to compare various analytical approaches.

Main Results:

  • Survival analysis provides a robust method for analyzing treatment efficacy when exercise tests are prematurely terminated.
  • Simulations demonstrated the advantages of survival analysis over traditional methods in handling censored data.
  • The proposed method accurately reflects treatment effects even with non-angina related test endings.

Conclusions:

  • Survival analysis is a suitable statistical approach for clinical trials evaluating angina treatments when exercise tests are censored by fatigue.
  • This method enhances the reliability of efficacy assessments in cardiovascular drug development.
  • The findings support the adoption of survival analysis for similar future trials.

Related Experiment Videos